Biopharm Enters into Co-Research Agreement with Merck
Collaboration in Osteoarthritis on discovery of protein with potential effect on joint cartilage formation
22-Nov-2013 -
Biopharm GmbH announced that they have signed an agreement with Merck to cooperate with Merck Serono, the biopharmaceutical division of Merck in their research activities directed toward the molecular engineering of a biologic compound for the treatment of osteoarthritis. Under the terms of the ...
cartilage
Merck
Merck Serono
+1